These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1325 related articles for article (PubMed ID: 29045477)
1. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway. Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477 [TBL] [Abstract][Full Text] [Related]
2. Tubastatin alleviates epidural fibrosis via negatively targeting TGFβ/PI3K/Akt pathway. Tao L; Wu L; Ge Y Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):231-236. PubMed ID: 38678601 [TBL] [Abstract][Full Text] [Related]
3. Eupatilin inhibits pulmonary fibrosis by activating Sestrin2/PI3K/Akt/mTOR dependent autophagy pathway. Gong H; Lyu X; Liu Y; Peng N; Tan S; Dong L; Zhang X Life Sci; 2023 Dec; 334():122218. PubMed ID: 37918625 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 alleviates idiopathic pulmonary fibrosis by inhibiting PI3K-AKT-mTOR signaling and stimulating autophagy. Qi J; Wu Y; Guo Z; Zhu S; Xiong J; Hu F; Liang X; Ye X Int J Biol Macromol; 2024 Jul; 273(Pt 1):132896. PubMed ID: 38851619 [TBL] [Abstract][Full Text] [Related]
5. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes. Choi SY; Ryu Y; Kee HJ; Cho SN; Kim GR; Cho JY; Kim HS; Kim IK; Jeong MH Vascul Pharmacol; 2015 Sep; 72():130-40. PubMed ID: 25921924 [TBL] [Abstract][Full Text] [Related]
6. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis. Zhang L; Li Y; Liang C; Yang W Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150 [TBL] [Abstract][Full Text] [Related]
7. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis. Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491 [No Abstract] [Full Text] [Related]
8. TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner. Wygrecka M; Zakrzewicz D; Taborski B; Didiasova M; Kwapiszewska G; Preissner KT; Markart P Am J Respir Cell Mol Biol; 2012 Nov; 47(5):614-27. PubMed ID: 22771387 [TBL] [Abstract][Full Text] [Related]
9. Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib. Bourne MH; Kottom TJ; Hebrink DM; Choudhury M; Leof EB; Limper AH Cells; 2021 Dec; 10(12):. PubMed ID: 34944010 [TBL] [Abstract][Full Text] [Related]
10. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression. Liu MW; Su MX; Tang DY; Hao L; Xun XH; Huang YQ BMC Pulm Med; 2019 Feb; 19(1):35. PubMed ID: 30744607 [TBL] [Abstract][Full Text] [Related]
11. Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice. Pan L; Cheng Y; Yang W; Wu X; Zhu H; Hu M; Zhang Y; Zhang M Inflammation; 2023 Aug; 46(4):1531-1542. PubMed ID: 37160579 [TBL] [Abstract][Full Text] [Related]
12. Isoliquiritigenin inhibits TGF-β1-induced fibrogenesis through activating autophagy via PI3K/AKT/mTOR pathway in MRC-5 cells. He J; Peng H; Wang M; Liu Y; Guo X; Wang B; Dai L; Cheng X; Meng Z; Yuan L; Cai F; Tang Y Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):810-820. PubMed ID: 32638014 [TBL] [Abstract][Full Text] [Related]
13. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment]. Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559 [TBL] [Abstract][Full Text] [Related]
14. ESL attenuates BLM-induced IPF in mice: Dual mediation of the TLR4/NF-κB and TGF-β1/PI3K/Akt/FOXO3a pathways. Jia C; Yang M; Xiao G; Zeng Z; Li L; Li Y; Jiang J; Xu A; Qiu J; Tang R; Li D; Jia D; Xie C; Wu G; Cai D; Bi X Phytomedicine; 2024 Sep; 132():155545. PubMed ID: 38972238 [TBL] [Abstract][Full Text] [Related]
15. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling. Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047 [TBL] [Abstract][Full Text] [Related]
16. [Effect of Peitu Yifei Granules on autophagy mechanism in rats with idiopathic pulmonary fibrosis based on PI3K/Akt/mTOR signaling pathway]. Fan ZK; Niu XY; Wang LD; Niu YY; Wang LJ; Wang X; Wu YQ; Zhang RT Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(14):3878-3886. PubMed ID: 39099361 [TBL] [Abstract][Full Text] [Related]
17. Aspirin alleviates pulmonary fibrosis through PI3K/AKT/mTOR-mediated autophagy pathway. Peng J; Xiao X; Li S; Lyu X; Gong H; Tan S; Dong L; Sanders YY; Zhang X Exp Gerontol; 2023 Feb; 172():112085. PubMed ID: 36623738 [TBL] [Abstract][Full Text] [Related]
18. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema. Yu J; Ma Z; Shetty S; Ma M; Fu J Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059 [TBL] [Abstract][Full Text] [Related]
19. Trichostatin A attenuates ventilation-augmented epithelial-mesenchymal transition in mice with bleomycin-induced acute lung injury by suppressing the Akt pathway. Li LF; Lee CS; Lin CW; Chen NH; Chuang LP; Hung CY; Liu YY PLoS One; 2017; 12(2):e0172571. PubMed ID: 28234968 [TBL] [Abstract][Full Text] [Related]
20. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]